About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 1944 blog entries.

South Carolina

Effective for dates of service on or after Sept. 15, 2022, the South Carolina Department of Health, and Human Services (SCDHHS) will expand coverage for additional pneumococcal immunizations for Healthy Connections Medicaid members 19 years of age and older under the pharmacy and medical benefit.  

SCDHHS will reimburse providers for the administration of the immunizations in accordance with the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule for the following Healthcare Common Procedure Coding System (HCPCS) codes:  

  • Pneumococcal 15-valent conjugate vaccine (PCV15): HCPCS Code 90671 
  • Pneumococcal 20-valent conjugate vaccine (PCV20): HCPCS Code 90677 

The new codes will be reflected on the Physicians Fee Schedule and updates to the Physicians Services provider manual will be available by Sept. 15, 2022. 

Pharmacy reimbursement utilizes the standard basis of payment for the fee-for-service pharmacy benefit at the lowest of: 

  • The actual acquisition cost (AAC) plus a professional dispensing fee (PDF) of $10.50; 
  • The state’s maximum allowable cost plus a PDF of $10.50; or, 
  • The usual and customary charges to the public. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-09-16T09:45:59-04:00September 16, 2022|South Carolina|

Texas

The Health and Human Services Commission’s (HHSC) Executive Commissioner Cecile Erwin Young announced that Dr. Jennifer Shuford will serve as interim commissioner of the Texas Department of State Health Services (DSHS), effective October 2022, replacing Dr. John Hellerstedt who is retiring from state service. Shuford currently serves as chief state epidemiologist at DSHS. She is also a member of the Texas Medical Association, where she serves as a consultant to TMA’s Committee on Infectious Diseases. 

Also in Texas, the September draft specialty drug list has been posted. Comments are due by September 22, 2022. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-09-16T09:45:20-04:00September 16, 2022|Texas|

Virginia

The Department of Health has issued an updated standing order for COVID vaccines reflecting current CDC (Centers for Disease Control) recommendations.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-09-16T09:44:47-04:00September 16, 2022|Virginia|

Washington

The Health Care Authority (HCA) has made the following updates to its COVID-19 monoclonal antibody policy concerning HCPCS code Q0222: 

  • Do not bill using HCPCS code Q0222 if the product was received free of charge through the United States Government (USG)-purchased inventory. 
  • Bill HCA for commercially purchased products only. 

See Apple Health Monoclonal Antibody Treatment COVID-19 clinical policy, under COVID-19, Policies, and billing guidance for more information regarding the policy and procedure codes involved. 

HCA revised the COVID-19 Fee Schedule. See HCA’s Provider billing guides and fee schedules, under COVID-19. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-09-16T09:43:50-04:00September 16, 2022|Washington|

Alabama

The Alabama Medicaid Agency will provide a COVID-19 public health emergency (PHE) update for Medicaid providers and partners on September 15, 2022. Agency representatives will share how the Agency is preparing for the end of the PHE and the return to normal operations. The meeting is offered for attendees both in-person or virtual (online or by phone).  

Medicaid providers, staff, operating state agencies, professional groups, advocacy groups, and all partners who interact with Medicaid recipients are encouraged to attend.  

Also in Alabama, please find the updated Synagis® Criteria for Summer 2022 (as part of the 2021-2022 Season); and the Use of Synagis® in the 2022–2023 Season here.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-08-19T10:46:29-04:00August 19, 2022|Alabama|

Arkansas

Test & Treat Protocols for both strep and flu were finally approved by the Arkansas Medical Board in August. Previously, these rules were approved by the Pharmacy Board in June. Act 503 passed in 2021 authorized Arkansas pharmacists to test, screen, and treat patients for influenza and pharyngitis caused by streptococcus A within the framework of a written statewide protocol. Arkansas pharmacists may develop their own policies and procedures and begin offering the service, and bill for these services utilizing their own NPI number. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-10-10T09:01:58-04:00August 19, 2022|Arkansas|

California

Medi-Cal posted the following: 

Also in California, the Department of Health Care Services posted the following alerts on the Medi-Cal Rx Web Portal. 

 

Finally in California, the Board of Pharmacy communicated the following: 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-08-19T10:45:13-04:00August 19, 2022|California|

Colorado

Gov. Jared Polis’ (D) administration and the Department of Health Care Policy & Financing (HCPF) announced partnerships with key supply chain partners that will help Colorado operationalize the importation of drugs. Colorado’s Canadian Importation Program, once approved by the Food and Drug Administration (FDA), estimated it will save Coloradoans an average of more than 60% on prescription medications.  

Also in Colorado, on August 28 the Division of Profession and Occupations will hold a Joint Stakeholder online seminar with Pharmacy and other Healthcare Boards with prescriptive authority to solicit input from stakeholders on the implementation of House Bill 22-1115, clarifying certain provisions in the Prescription Drug Monitoring Program. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-08-19T10:44:25-04:00August 19, 2022|Colorado|
Go to Top